Regulation of gene expression, growth, and cell survival by IL-4: Contribution of multiple signaling pathways

Cell Research

Volumn 8, Issue 1, 1998, Pages 1-13

  Keegan, Achsah D ^a   Zamoran, Jose ^a  

^a HOLLAND LABORATORY   (United States)

Author keywords

Cytokines; Lymphocytes; Receptors; Signal transduction; Tyrosine phosphorylation

Indexed keywords

INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR;

AMINO ACID SEQUENCE; CELL DIVISION; CYTOLOGY; GENE EXPRESSION REGULATION; HUMAN; LYMPHOCYTE; MOLECULAR GENETICS; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; CELL DIVISION; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-4; LYMPHOCYTES; MOLECULAR SEQUENCE DATA; RECEPTORS, INTERLEUKIN-4; SIGNAL TRANSDUCTION;

EID: 0032018175     PISSN: 10010602     EISSN: None     Source Type: Journal    
DOI: 10.1038/cr.1998.1     Document Type: Article

References (87)

1. Paul WE. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 1991; 77:1859-65.
2. Seder PA, Paul WE. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Ann Rev Immunol 1994; 12:635-73.
3. Coffman RL, Ohara J, Bond MW, Carty J, Zlotnick A, Paul WE. B cell stimulatory factor- 1 enhances the IgE response of LPS-activated B cells. J Immunol 1986; 136:4538-41.
4. Schleimer RP, Sterbinsky SA, Kaiser J, et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol 1992; 198:1086-92.
5. Lowenthal JW, Castle BE, Christiansen J, et al. Expression of high affinity receptors for murine IL-4 on hemopoietic and nonhemopoietic cells. J Immunol 1988; 140:456-64.
6. Ohara J, Paul WE. Receptors for B-cell stimulatory factor-1 expressed on cells of haematopoietic lineage. Nature 1987; 325: 537-40.
7. Park LS, Friend D, Grabstein K, Urdal DL. Characterization of the highaffinity cell- surface receptor for murine B-cell-stimulating factor 1. Proc Natl Acad Sci USA 1987; 84:1669-73.
8. Mosley B, Beckmann MP, March CJ, et al. The murine IL-4 receptor: Molecular cloning and characterization of secreted and membrane bound forms. Cell 1989; 59:335-48
9. Harada N, Castle BE, Gorman DM, et al. Expression cloning of a cDNA encoding the murine IL-4 receptor based on ligand binding. Proc Natl Acad Sci USA 1990; 87:857-61.
10. Idzerda RL, March CJ, Mosley B, et al. Human IL-4 receptor confers biological responsiveness and defines a novel receptor superfamily. J Exp Med 1990; 171: 861-73
11. Galizzi JP, Zuber CE, Harada N, et al. Molecular cloning of a cDNA encoding the human IL-4 receptor. Intl Immunol 1990; 2:669-75.
12. Cosman D. The hematopoietin receptor superfamily. Cytokin 1993; 5: 95-106.
13. Wrighton N, Campbell LA, Harada N, Miyajima A, Lee F. The murine interleukin4- receptor gene: genomic structure, expression and potential for alternative splicing. Growth Factors. 1992; 6:103-118.
14. Russell SM, Keegan AD, Harada N, et al. The interleukin-2 receptor chain is a functional component of the interleukin-4 receptor. Science 1993; 262: 1880-3.
15. Callard RE, Matthews DJ Hibbert L. IL-4 and IL13 receptors: are they one and the same? Immunol. Today 1996; 17:108-10.
16. Hilton DJ, Zhang J-G, Metcalf D, Alexander WS, Nicola NA, Willson TA. Cloning and characterization of a binding subunit of the IL-13 receptor tht is also a component of the IL-4 receptor. Proc Natl Acad Sci USA 1996; 93: 497-501.
17. Aman MJ, Tayebi N, Obiri NI, Puri RK, Modi WS, Leonard WJ. cDNA cloningand characterization of the human interleukin 13 receptor alpha chain. J Biol Chem 1996; 27146:29265-70.
18. Caput D, Laurent P, Kaghad M, Lelias J-M, Lefort S, Vito N, Ferrara P. Cloning and characterization of a specific IL-13 binding protein structurally related tot he IL-5 receptor alpha chain. J Biol Chem 1996; 271:16921-6.
19. Finney M, Guy GR, Michell RH. Interleukin 4 activates human B lymphocytes via transient inositol lipid hydrolysis and delayed cyclic adenosine monophosphate generation. 1990; 20:151-6.
20. Keegan AD, Nelms K, Wang LM, Pierce JH, Paul WE. Interleukin 4 receptor: Signaling mechanisms. Immunol Today 1994; 15:423-32.
21. Ihle JN. Cytokine receptor signaling. Nature 1995; 377:591-4.
22. Yin T, Tsang ML-S, Yang Y-C. JAK1 kinase forms complexes with IL-4 receptor and 4PS/IRS1 protein and is activated by IL-4 and IL-9 in T lymphocytes. Biol Chem 1994; 269:26614-7.
23. Miyazaki T, Kawahara A, Fujii H, et al. Functional activation of JAK1 and JAK3 by selective association with the IL-2 receptor subunits. Science 1994; 266:1045-7.
24. Russell SM, Johnston JA, Noguchi M, et al. Interactions of teh IL-2 receptor chains with JAK1 and JAK3: Implications for XSCID and XCID. Science 1994; 266: 1042-5.
25. Witthuhn BA, Silvennoinen O, Miura O, et al. Involvement of the JAK3 kinase in signaling by IL-2 and IL-4 in lymphoid and myeloid cells. Nature 1994; 370:153-7.
26. Johnston JA, Kawamura M, Kirken RA, et al. Phosphorylation and activation of the JAK3 kinase in response to IL-2. Nature 1994; 370:151-7.
27. Murata T, Noguchi PD, Puri RK. Receptors for IL-4 do not associate with the common gamma chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells. J Biol Chem 1996; 270:30829-36.
28. Welham MJ, Learmouth L, Bone H, Schrader JW. IL-13 signal transduction in lymphohemopoietic cells: Similarities and differences in signal transduction with IL-4 and insulin. J Biol Chem 1995; 270:12286-96.
29. Lin J-X, Migone TS, Tsang M, et al. Towards a molecular understanding of cytokine peiotrophy and redendancy: IL-2, IL-4, IL-7, and IL-13 activated STAT proteins. Immunity 1995; 2:331-339.
30. He YW, Adkins B, Furse RK, and Malek TR. Expression and function of the re subunit of the IL-3, IL-4, and IL-7 receptors. Distinct interactions of γc in the IL-4 receptor. J Immunol 1995; 154:1596-1605.
31. Matthews DJ, Clark PA, Herbert J, et al. Function of the IL-2 receptor gamma- chain in biologicresponses of X- linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-15.1995; 85:38-42.
32. Lai SY, Molden J, Liu KD, Puck JM, White MF, Goldsmith MA. IL-4-specific signal transduction events are driven by homotypeic interactions of hte IL-4 receptor subunit. EMBO J 1996;15: 4506-14.
33. Oakes S, Johnston J, Candotti F, et al. Signaling via IL-2 and IL-4 in JAK-3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and -independent pathways.Immunity 1996; 5:605-15.
34. Wang HY, Zamorano J, Yoerkie JL, Paul WE, Keegan AD. The IL-4-induced tyrosine phosphorylationof the insulin receptor substrate (IRS) is dependent on JAK-1 expression in humanfibrosarcoma cells. J Immunol 1997; 158:1037-40.
35. Chen XH, Wang LM, Patel BKR, Flavell RA, LaRochelle WJ, Pierce JH. JAK1 expression isrequired for mediating tyrosine phosphorylation of signaling molecules in response to IL-4. JBiol Chem 1997; 272:6556-60.
36. Malabarba MG, Kirken RA, Rui H, Koettnitz K, Kawamura M, O'Shea JJ, Kalthoff FS, FarrarWL. Activation of JAK3, but not JAK1, is critical to interleukin-4 (IL-4) stimulated proliferationand requires a membraneproximal region of IL-4 receptor alpha. J Biol Chem. 1995; 270:9630-7.
37. Darnell JE, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in responseto IFNs and other extracellular signaling proteins. Science 1994; 264:1415-21.
38. Kohler I, Rieber EP. Allergy associated Iepsilon and Fcepsilon receptor II (CD23b) genes activated via binding of an IL-4-induced transcription factor to a novel responsive element. Eur JImmunol 1993; 23:3066-71.
39. Kotanides H, Reich NC. Requirement of tyrosine phosphorylation for rapid activation of a DNAbinding factor by IL-4. Science 1993; 262:1265-7.
40. Schindler C, Kashleva H, Pernis A, Pine R, Rothman P. STFIL4: a novel IL-4-induced signaltransducing factor. EMBO J 1994; 13:1350-6.
41. Hou J, Schindler U, Henzel WJ, Ho TC, Brasseur M, McKnight SL. An IL-4 induced transcription factor: IL4 STAT. Science 1994; 265:1701-6.
42. Quelle FW, Shimoda K, Thierfelder W, et al. Cloning of murine and human State (IL-4 Stat):A novel stat tyrosine phosphorylated in the responses to IL-4 and IL-3 that is not required formitogenesis. Mol Cell Biol 1995; 15:3336-43.
43. White MF and Kahn CR. The insulin signaling system. J Biol Chem 1994; 269, 14.
44. Sun X-J, Wang L-M, Zhang Y, et al. Role of IRS2 in insulin and cytokine signalling. 1995;377:173-7.
45. Araki E, Lipes MA, Patti ME, et al. Alternative pathway of insulin signaling in mice with atargeted gene disruption of the IRS1 gene. Nature 1994; 372:186-90.
46. Tamemoto H, Kadowaki T, Tobe K, et al. Insulin resistance and growth retardation in micelacking insulin receptor substratel. 1994; 372:182-6.
47. Sun XJ, Pons S, Wang LM, et al. The IRS2 gene on murine chromosome 8 encodes a uniquesignaling adapter for insulin and cytokine action. Mol Endocrinol 1997; 11:25162.
48. Zamorano J, Wang HY, Wang LM, Pierce JH, Keegan AD. IL-4 protect cells from apoptosis viathe insulin receptor substrate pathway and a second independent signaling pathway. J Immunol1996; 157:4926-34.
49. Welham MJ, Bone H, Levings M, et al. Insulin receptor substrate-2 is the major 170-kDa proteinphosphorylated on tyrosine in response to cytokines in murine lymphohemopoietic cells. J BiolChem 1997; 272:137781.
50. Johnston JA, Wang LM, Hanson EP, et al. Interleukins 2, 4, 7, and 15 stimulate tyrosinephosphorylation of insulin receptor substrates 1 and 2 in T cells. Potential role of JAK kinases.J Biol Chem 1995; 270:28527-30.
51. Sharfe N, Roifman CM. Differential association of phosphatidylinositol 3-kinase with insulinreceptor substrate (IRS)-1 and IRS2 in human thymocytes in response to IL-7. J Immunol1997; 159:1107-14.
52. Izuhara K, Feldman RA, Greer P, et al. Interaction of the cfes protooncogene product with theIL-4 receptor. J Biol Chem 1994; 269:18623-9.
53. Crowley MT, Harmer SL, and DeFranco AL. Activation induced association of a 145 kDatyrosine-phosphorylated protein with she and syk in B lymphocytes and macrophages. Chem1996; 271:1145-52.
54. Izuhara K, Feldman RA, Greer P, Harada N. J IL-4 induces association of the cfes protooncogene product with PI 3 kinase. Blood. 1996; 88:3010-3918.
55. Schultz C, Izuhara K, Cöffman R, Harada N. The critical region in the cytoplasmic domain ofhuman IL-4 receptor for induction of IgE synthesis. Immunol Lett 1995; 46:215-9.
56. Nelms K, Snow A, Hu-Li J, Paul WE. Identification of a hematopoietic cell specific rasGAPinteracting protein. Submitted.
57. Wang LM, Keegan AD, Li W, et al. Common elements in IL4 and insulin signaling pathwaysin factor-dependent hematopoietic cells. Proc Natl Acad Sci 1993; 90:4032-6.
58. Wang L-M, Myers MG Jr, Sun X-J, Aaronson S̀A, White M, Pierce JH. Expression offRS1restores insulin and IL-4 mediated mitogenesis. 1993; 261: 1591-4.
59. Keegan AD, Nelms K, White MF, Wang LM, Pierce JH, Paul WE. An IL-4 receptor regioncontaining an insulin receptor motif is important for IL-4 mediated IRS1 phosphorylation andproliferation. Cell 1994; 76:811-20.
60. Wang HY, Paul WE, Keegan AD. IL-4 function can be transferred to the IL-2 receptor bytyrosine containing sequences found in the IL-4 receptoralpha chain. Immunity. 1996 4:113-21.
61. Wolf G, Trub T, Ottinger E, Groninga L, Lynch A, et al. PTB domains of IRS1 and She havedistinct but overlapping binding specificities. J Biol Chem 1995; 270:27407-10.
62. Zhou MM, Huang B., Olejniczak ET, Meadows RP et al. Structural basis for IL-4 receptorphosphopeptide recognition by the IRS1 PTB domain. Nature Struct Biol 1996; 3:388-93.
63. Kaplan MH, Schindler U, Smiley ST, Grusby MJ. STAT6 is required for mediating response toIL-4 and for the development of Th2 cells. Immunity 1996; 4:313-9.
64. Takeda K, Tanaka T, Shi W, et al. Essential role of STAT6 in IL-4 signaling. Nature 1996;380:627-9.
65. Shimoda K, Deursen J, Sangster MY, et al. Lack of IL-4-induced Th2 response and IgE classswitching in mice with disrupted STAT6 gene. Nature 1996; 380:630-3.
66. Karras JG, Wang Z, Coniglio SJ, Frank DA, Rothstein TL. Antigen receptor engagement in Bcells induces nuclear expression of STATS and STAT6 protein that bind and transactivate anIFN activation site. J Immunol 1996; 157:39-47.
67. Karras JG, Wang Z, Huo L, Frank DA, Rothstein TL. Induction of STAT protein signalingthrough the CD40 receptor in B lymphocytes. J Immunol 1997; 159:4350-5.
68. Ghilardi N, Ziegler S, Wiestner A, Stoffel R, Heim MH Skoda RC. Defective STAT signaling bythe leptin receptor in diabetic mice. Proc Natl Acad Sci USA 1996; 93:6231-5.
69. Patel BKR, Wang L-M, Lee CC, Taylor WG, Pierce JH, LaRochelle WJ. STAT6 and 6. JAK1are common elements in PDGF and IL-4 signal transduction pathways in NIH 3T3 fibroblasts.J Biol Chem 1996; 271:22175-82.
70. Ryan JJ, McReynolds LJ, Wang LH, et al. IL-4-induced growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. Immunity 1996; 4:123-32.
71. Wang DZ, Zamorano J, Keegan AD, Boothby MR. HMG-I(Y) phosphorylation status as nucleartarget regulated through IRS1 and the I4R motif of the IL-4 receptor. J Biol Chem 1997;272:25083-90.
72. Kim J, Reeves R, Rothman P, Boothby M. The non- histone chromosomal protein HMG-I(Y)contributes to repression of the immunoglobulin heavy chain germ-line epsilon RNA promoter.Eur J Immunol 1995; 253:798-808.
73. Wang DZ, Ray P, Boothby M. Interleukin-4-inducible phosphorylation of HMGI(Y) is inhibit-edby rapamycin. J Biol Chem 1995; 270:22924-32
74. Ales-Martinez JE, Cuenda E, Gaur A, Scott DW. Prevention of B cell clonal deletion and anergyby activated T cells and their lymphokines. Sem in Immunol 1992; 4:195-205.
75. Parry SL, Hasbold J, Holman M, Klaus GG. Hypercross-linking surface IgM or IgD receptorson mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti- CD40.J Immunol 1994; 152:2821-9.
76. Phillips NE, Gravel KA, Tumas K, Parker DC. 1988. IL-4 (B cell stimulatory factor 1) overcomesFc receptor-mediated inhibition of mouse B lymphocyte proliferation without affecting inhibitionof c-myc mRNA induction. J Immunol 1988; 141:4243-9.
77. Foote LC, Howard, RG, Marshak-Rothstein A, Rothstein, TL. IL-4 induces Fas resistance in Bcells J Immunol 1996; 157:2749-53.
78. Franke TF, Kaplan DR, Cantley LC. PI3K: Downstream AKTion blocks apoptosis. Cell 1997;88:435-7.
79. Myers MG, Grammar TC, Wang LM, et al. Insulin receptor substrate-1 mediates phosphatidylinositol3, kinase and p70S6K signaling during insulin, insulinlike growth factor1 and interleukin-4stimulation. J Biol Chem 1994; 2694:28783-9.
80. Datta SR, Dudek H, Tao Z, et al. AKT phosphorylation of BAD couples survival signals to thecell-intrinsic death machinery. Cell 1997; 91:231-41.
81. Zamorano J, Austrian J, Wang HY, Keegan AD. Costimulation of resting B lymphocytes altersthe IL-4activated IRS2 signaling pathway leading to protection from apoptosis and proliferation:Roles of IRS2 and STAT6. Submitted.
82. Vella A, Teague TK, Ihle J, Kappler J, Marrack P. IL-4 or IL-7 prevents the death of resting Tcells: Stat6 is probably not requried for the effect of IL-4. J Exp Med 1997; 186:325-30.
83. Danescu M, Rubio-Trujillo, Biron G, et al. IL-4 protects chronic lymphocytic leukemic B cellsfrom death by apoptosis and upregulates bcl-2 expression. J Exp Med 1992; 179: 1319-26.
84. Boise LH, Minn AJ, June CH, Lindsten T, Thompson CB. Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division. Proc Natl Acad Sci USA1995; 92:5491-5.
85. Choi MSK, Holman M, Atkins CJ, Klaus GGB. Expression of blcx during mouse B cell differentiation and following activation by various stimuli. Eur J Immunol 1996; 26:676-82.
86. Minshall C, Arkins S, Straza J, et al. IL4 and insulinlike growth factorI inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors. J Immunol 1997; 159:1225-32.
87. Bellosillo B, Dalmau M, Colomer D, and Gil J. Involvement of CED-3/ICE proteases in theapoptosis of B- chronic lymphocytic leukemia cells. Blood 1997; 89:3378-84.